Hawaii

Hawai'i

30,811 Registered Patient Population

2.17% of Total Population Represented by Patients

13 Total Medical Retail Locations Currently in Operation

2,370 : 1 Patients : Retail

Medical cannabis is legal in Hawaii, patients and caregivers may purchase from a dispensary or cultivate up to seven plants at home. Possession for patients and caregivers is limited to 4 ounces. Patients report access issues stemming from limited dispensaries, with some islands lacking one entirely. Patients visiting Hawaii can apply online for a 60 day registration card; the card costs a $49.50 fee and allows visitors to shop at Hawaii’s dispensaries.

Patient Rights and Civil Protection	94/100
Arrest Protection 40/40 Affirmative Defense 15/15 Parental Rights Protections 10/10 DUI Protections 0/5 Employment Protections 5/5 Explicit Privacy Standards 7/7 Housing Protections 5/5 Does Not Create New Criminal Penalties for Patients 4/5 Organ Transplants 5/5 Reciprocity 3/3
Access to Medicine	82/100
Allows Distribution Programs 27/40 – Allows Access to Dried Flowers 15/15 – Allows Delivery 0/5 – No Sales Tax or Reasonable Sales Tax 4/5 – Allows for a Reasonable Number of Dispensaries 5/5 – Does Not Require Vertical Integration 0/2 – Ownership/Employment Restrictions 1/2 – Provisions for Labor Standards 0/2 – Environmental Impact Regulations 0/2 – Choice of Dispensary Without Restrictions 2/2 Noncommercial Cultivation 18/20 – Personal Cultivation 15/15 – Collective Gardening 3/5 Explicit Right to Edibles/Concentrates/Other Forms 10/10 Does not Impose Bans or Limits on THC 10/10 Does not Impose Bans on CBD 10/10 Local Bans/Zoning 7/10
Ease of Navigation	94/100
Comprehensive Qualifying Conditions 48/50 Adding New Conditions 9/10 – Law/Regulations Allow for New Conditions 5/5 – System Works for Adding New Conditions 4/5 Reasonable Access for Minors 9/10 Reasonable Caregiver Background Checks 4/4 Number of Caregivers 2/2 Patient/Practitioner-Focused Task Force or Advisory Board 2/2 Reasonable Fees (Patients and Caregivers) 9/10 Allows Multiple-Year Registrations 2/2 Reasonable Physician Requirements 4/5 Does Not Classify Cannabis as a Medicine of Last Resort 5/5
Functionality	83/100
Patients Able to Access Medicine at Dispensaries or by Cultivation 45/50 No Significant Administrative or Supply Problems 14/15 Patients Can Receive Legal Protections Within Reasonable Time Frame of Doctor's Recommendation 7/10 Reasonable Possession Limits 5/5 Reasonable Purchase Limits 4/5 Allows Patients to Medicate Where They Choose 4/5 Covered by Insurance/State Health Aid 0/3 Financial Hardship (Fee Waivers/Discount Medicine) 4/7
Consumer Safety and Provider Requirements	78.18/100
Dispensing 18.34/25 Staff Training 5/5 Standard Operating Procedures 5/5 – Facility Sanitary Conditions 1.25/1.25 – Storage Protocols 1.25/1.25 – Reasonable Security Protocols 1.25/1.25 – Inventory Control 1.25/1.25 Recall Protocol and Adverse Event Reporting 0/5 Product Labeling 3.34/5 – Product Contents, Including Source Material Identification 1.67/1.67 – Allergens 0/1.67 – Potency/Compound Identification 1.67/1.67 Required Testing 5/5 – Active Compound Identification 1.67/1.67 – Contaminants 1.67/1.67 – Potency 1.67/1.67 Grow/Cultivation 18.5/25 Staff Training 5/5 Standard Operating Procedures 5/5 – Facility and Equipment Sanitary Conditions 0.71/0.71 – Workforce Safety Protocols 0.71/0.71 – Storage Protocols (Short-Term and Long-Term Storage) 0.71/0.71 – Reasonable Security Protocols 0.71/0.71 – Batch and Lot Tracking 0.71/0.71 – Disposal/Waste 0.71/0.71 – Water Management 0.71/0.71 Pesticide Guidance 3.5/5 – Pesticide Guidance 2.5/2.5 – Pesticide Labeling 1/2.5 Required Testing 5/5 – Active Ingredient Identification 1.25/1.25 – Contaminants 1.25/1.25 – Potency 1.25/1.25 – Sample Retention 1.25/1.25 Recall Protocol and Adverse Event Reporting 0/5 Manufacturing 17.34/25 Staff Training 5/5 Standard Operating Procedures 5/5 – Facility and Equipment Sanitary Conditions 1/1 – Workforce Safety Protocols 1/1 – Storage Protocols 1/1 – Reasonable Security Protocols 1/1 – Batch and Lot Tracking 1/1 Product Labeling 3.34/5 – Product Contents, Including Source Material Identification 1.67/1.67 – Allergens 0/1.67 – Potency and Compound Information 1.67/1.67 Required Testing 4/5 – Active Ingredient Identification 1/1 – Contaminants 1/1 – Potency 1/1 – Shelf Life Testing 0/1 – Sample Retention 1/1 Recall Protocol and Adverse Event Reporting 0/5 Laboratory Operations 24/25 Staff Training 5/5 Method Validation in Accordance with AHPA Guidelines 5/5 Result Reporting 4/5 Independent or Third Party 5/5 Standard Operating Procedures and Protocols 5/5 – Equipment and Instrument Calibration 0.83/0.83 – Sample Tracking 0.83/0.83 – Facility and Equipment Sanitary Conditions 0.83/0.83 – Disposal/Waste 0.83/0.83 – Storage Protocols 0.83/0.83 – Workforce Safety Protocols 0.83/0.83
Covid Response	10/20
Delivery Available? 0/6 Curbside Pickup Available? 0/2 Medical Cannabis Essential? 7/7 Telemedicine Available? 3/5
Excerpted from ASA's 2020 State of the States Report.

Becoming a Patient in Hawai'i

Recommending Cannabis in Hawai'i

History of Medical Cannabis in Hawaii

Policy Recommendations Hawaii